Profil
Stephen Lichaw is currently the Vice President-Business Development at Lirum Therapeutics, Inc. He previously worked as a Managing Director at Middlebury Securities LLC and as a Principal at Ladenburg Thalmann & Co., Inc. Mr. Lichaw holds an MBA from Cornell University and an undergraduate degree from the University of Hartford.
Aktiva positioner av Stephen Lichaw
| Företag | Position | Start |
|---|---|---|
| LIRUM THERAPEUTICS, INC. | Företagsledare/Principal | 2022-08-01 |
Tidigare kända positioner av Stephen Lichaw
| Företag | Position | Slut |
|---|---|---|
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Företagsledare/Principal | - |
Middlebury Securities LLC
Middlebury Securities LLC Investment ManagersFinance Middlebury Securities invests in companies located in the United States. The firm focuses on life sciences sector. The firm participates in early stage capital funding and lending of structured debt. | Privat kapitalinvesterare | - |
Stephen Lichaws utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hartford
University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Finance |
Middlebury Securities LLC
Middlebury Securities LLC Investment ManagersFinance Middlebury Securities invests in companies located in the United States. The firm focuses on life sciences sector. The firm participates in early stage capital funding and lending of structured debt. | Finance |
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
















